"Does Primary Tumor Resection Affect Survival in Oligometastatic Renal Cancer?" and “Pembrolizumab (Keytruda) Use in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Appraising the Data”
June 10, 2021Information
June 4, 2021: Folawiyo Laditi, Sub Intern, Yale School of Medicine; Iain Drew, Sub Intern, Frank H. Netter MD, School of Medicine, Quinnipiac University
ID6704
To CiteDCA Citation Guide